WeberWP, MujagicE, ZwahlenM, et al.Timing of surgical antimicrobial prophylaxis: A phase 3 randomised controlled trial. Lancet Infect Dis, 2017; 17:605–14.
2.
DeierhoiRJ, DawesLG, VickC, ItaniKM, HawnMT. Choice of intravenous antibiotic prophylaxis for colorectal surgery does matter. J Am Coll Surg, 2013; 217:763–9.
3.
HendrenS, FritzeD, BanerjeeM, et al.Antibiotic choice is independently associated with risk of surgical site infection after colectomy: A population-based cohort study. Ann Surg, 2013; 257:469–475.
4.
PoeranJ, WassermanI, ZubizarretaN, MazumdarM. Characteristics of antibiotic prophylaxis and risk of surgical site infections in open colectomies. Dis Colon Rectum, 2016; 59:733–742.
5.
TillSR, MorganDM, BazziAA, et al.Reducing surgical site infections after hysterectomy: Metronidazole plus cefazolin compared with cephalosporin alone. Am J Obstet Gynecol, 2017; 217:187.e1–.e11.
6.
GoldsteinEJ, CitronDM, MerriamCV, AbramsonMA. Infection after elective colorectal surgery: Bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis. Surg Infect, 2009; 10:111–118.
7.
Cordero-LaurentE, RodriguezC, Rodriguez-CavalliniE, et al.Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ss-lactams, clindamycin, metronidazole, and chloramphenicol. Rev Esp Quimioter, 2012; 25:261–265.
8.
BoyanovaL, KolarovR, MitovI. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe, 2015; 31:4–10.
9.
YimJ, LeeY, KimM, et al.Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital. Ann Lab Med, 2015; 35:94–98.
10.
ClassenDC, EvansRS, PestotnikSL, et al.The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection [see comments]. N Engl J Med, 1992; 326:281–286.
11.
GareyKW, DaoT, ChenH, et al.Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother, 2006; 58:645–650.
12.
ParkerBM, HendersonJM, VitaglianoS, et al.Six sigma methodology can be used to improve adherence for antibiotic prophylaxis in patients undergoing noncardiac surgery. Anesth Analg, 2007; 104:140–146.
13.
RosenbergAD, WamboldD, KraemerL, et al.Ensuring appropriate timing of antimicrobial prophylaxis. J Bone Joint Surg Am, 2008; 90:226–232.
14.
SteinbergJP, BraunBI, HellingerWC, et al.Timing of antimicrobial prophylaxis and the risk of surgical site infections: Results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg, 2009; 250:10–16.
15.
KochCG, NowickiER, RajeswaranJ, et al.When the timing is right: Antibiotic timing and infection after cardiac surgery. J Thorac Cardiovasc Surg, 2012; 144:931–937 e4.
16.
KochCG, LiL, HixsonE, et al.Is it time to refine? An exploration and simulation of optimal antibiotic timing in general surgery. J Am Coll Surg, 2013; 217:628–635.
17.
MullerA, LeroyJ, HenonT, et al.Surgical antibiotic prophylaxis compliance in a university hospital. Anaesth Crit Care Pain Med, 2015; 34:289–294.
18.
BratzlerDW, HouckPM, RichardsC, et al.Use of antimicrobial prophylaxis for major surgery: Baseline results from the national surgical infection prevention project. Arch Surg, 2005; 140:174–182.
19.
BratzlerDW, DellingerEP, OlsenKM, et al.Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect, 2013; 14:73–156.
20.
Metronidazole Injection, USP RTU® in Plastic Container VIAFLEX Plus Container. 2009:5–17.
21.
LoftS, DossingM, PoulsenHE, et al.Influence of dose and route of administration on disposition of metronidazole and its major metabolites. Eur J Clin Pharmacol, 1986; 30:467–473.
22.
MannistoP, KarhunenM, MattilaJ, et al.Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration. Infection, 1984; 12:197–201.
23.
Ioannides-DemosLL, FarmerC, SpicerWJ, McLeanAJ. Design and trial of a metronidazole loading dose regimen for patients undergoing emergency surgery. Aust N Z J Surg, 1989; 59:953–957.
24.
ZanellaE, RulliF. A multicenter randomized trial of prophylaxis with intravenous cefepime + metronidazole or ceftriaxone + metronidazole in colorectal surgery. The 230 Study Group. J Chemother, 2000; 12:63–71.
25.
HoughtonGW, SmithJ, ThornePS, TempletonR. The pharmacokinetics of oral and intravenous metronidazole in man. J Antimicrob Chemother, 1979; 5:621–623.
26.
VisserAA, HundtHK. The pharmacokinetics of a single intravenous dose of metronidazole in pregnant patients. J Antimicrob Chemother, 1984; 13:279–283.
27.
HoughtonGW, ThornePS, SmithJ, et al.Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol, 1979; 8:337–341.
28.
TiTY, LeeHS, KhooYM. Disposition of intravenous metronidazole in Asian surgical patients. Antimicrob Agents Chemother, 1996; 40:2248–2251.
29.
KlingPA, HolmlundD, BurmanLG. Prevention of post-operative infection in appendicectomy by single dose intravenous metronidazole. An open prospective randomised study. Acta Chir Scand, 1985; 151:73–76.
30.
KlingPA, HolmlundD, BurmanLG. Single-dose intravenous metronidazole v. doxycycline prophylaxis in colorectal surgery. An open prospective, randomized trial. Acta Chir Scand, 1985; 151:163–168.
31.
WeberWP, MartiWR, ZwahlenM, et al.The timing of surgical antimicrobial prophylaxis. Ann Surg, 2008; 247:918–926.
32.
RiversTE, WebsterAA. Stability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bags. Am J Health Syst Pharm, 1995; 52:2568–2570.
33.
Das GuptaV, StewartKR, Dela TorreM. Chemical stabilities of cefamandole nafate and metronidazole when mixed together for intravenous infusion. J Clin Hosp Pharm, 1985; 10:379–383.
34.
BarnesAR. Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion. J Clin Pharm Ther, 1990; 15:187–196.
35.
RiversTE, McBrideHA, TrangJM. Stability of cefotaxime sodium and metronidazole in an i.v. admixture at 8 degrees C. Am J Hosp Pharm, 1991; 48:2638–2640.
36.
BelliveauPP, NightingaleCH, QuintilianiR. Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags. Am J Health Syst Pharm, 1995; 52:1561–1563.
37.
NahataMC, EdmondsJJ, MoroscoRS. Stability of metronidazole and ceftizoxime sodium in ready-to-use metronidazole bags stored at 4 and 25 degrees C. Am J Health Syst Pharm, 1996; 53:1046–1048.
38.
BaileyLC, OroszSTJr. Stability of ceftriaxone sodium and metronidazole hydrochloride. Am J Health Syst Pharm, 1997; 54:424–427.
39.
NolinTD, LambertDA, OwensRCJr. Stability of cefepime and metronidazole prepared for simplified administration as a single product. Diagn Microbiol Infect Dis, 2006; 56:179–184.
